Corona vaccine trial stopped: subject probably has rare disease: “syndrome to be taken very seriously”

Updated September 10, 2020 at 2:05 pm: Research for one vaccine is considered one of the key factors for Sars-Cov-2 coronavirus to struggle. But now there was a big setback. The British-Swedish pharmaceutical company AstraZeneca had to interrupt the third and final phase of the clinical studies because one Topic Health problems have occurred.

Corona vaccine: study stopped – subject probably has a “syndrome that should be taken very seriously”

Until now, the group has remained covered regarding the exact disease. According to information from “New York Times” (we reported, see the first report) should be a Transverse myelitis, an inflammation of the spinal cord. In many cases, this would disappear completely, but “it is a syndrome that must be taken very seriously”, as the head of the Department of Infectious Diseases at the Regensburg University Hospital, Professor Bernd salzberger, in front of the newspaper “Bild”, said (article behind the payment barrier).

Now a time delay is inevitable. Dr. Rolf HömkeResearch Sprecer of the Association of Research-Based Pharmaceutical Companies told the newspaper that the study “could resume after a few days or weeks.” The spokesperson for the Minister of Health Jens spahn however, he claimed it was “scientific standard” for a study to be stopped because of a participant’s health problems.

Coronavirus – Vaccine Test Stopped – Test Subject Probably Got Sick With Rare Disease

Our initial report from September 9, 2020:

Munich: people around the world want you vaccine to be able to fight the corona pandemic * effectively. A company is well advanced in the development of a serum. The British-Swedish pharmaceutical company AstraZeneca It is one of nine corporations worldwide in the third and final phase of clinical studies and is considered a great hope. Tests were being conducted with tens of thousands of participants.

Corona vaccine: AstraZeneca has to interrupt the testing phase

But in the race for vaccine approval * you must AstraZeneca Now accept a big setback. Because a test person has had health problems, the clinic stopped for the moment. This is a routine measure “that should be carried out whenever a potentially unexplained illness occurs in any of the studies,” a company spokesman said.

It went on to say that the process had been voluntarily interrupted “to allow an independent committee to verify the safety data.”

Tests for corona vaccine interrupted: patient is said to have a rare neurological disease

What disease is it and where is the patient, had to AstraZeneca No information. But there are speculations and rumors. the New York Times wants to know from an informed person who is said to have transverse myelitis. This is a rare neurological disorder caused by inflammation of the central nervous system caused by viruses.

The one of AstraZeneca The active ingredient AZD1222 is based on the weakened version of a chimpanzee cold virus and is supposed to activate the immune system so that it can fight Sars-CoV-2 * in case of infection. (mt / dpa) * Merkur.de is part of the Ippen digital publishing network nationwide.

Headline list image: © Ted S. Warren / dpa